Cargando…
Current Status and Future Trends of Cold Atmospheric Plasma as an Oncotherapy
Cold atmospheric plasma (CAP), a redox modulation tool, is capable of inhibiting a wide spectrum of cancers and has thus been proposed as an emerging onco-therapy. However, with incremental successes consecutively reported on the anticancer efficacy of CAP, no consensus has been made on the types of...
Autores principales: | Dai, Xiaofeng, Wu, Jiale, Lu, Lianghui, Chen, Yuyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468422/ https://www.ncbi.nlm.nih.gov/pubmed/37641880 http://dx.doi.org/10.4062/biomolther.2023.027 |
Ejemplares similares
-
Cold atmospheric plasma: Novel opportunities for tumor microenvironment targeting
por: Dai, Xiaofeng, et al.
Publicado: (2023) -
PKM2 in carcinogenesis and oncotherapy
por: He, Xia, et al.
Publicado: (2017) -
Current and Potential Applications of Atmospheric Cold Plasma in the Food Industry
por: Khumsupan, Darin, et al.
Publicado: (2023) -
Cold Atmospheric Plasma: A Promising Controller of Cancer Cell States
por: Dai, Xiaofeng, et al.
Publicado: (2020) -
The Role of Toll-Like Receptors in Oncotherapy
por: Liu, Caiqi, et al.
Publicado: (2019)